Eight Roads Ventures
AUM $1.6 billion
Topics
News
- Delhi Launches Citywide AI Training Push for School Students
- Nexus Closes Eighth Fund at $700 Million for Early-Stage Bets in India and US
- Amazon to Pump $12.7 Billion into India’s AI and Cloud Expansion
- Anthropic Debuts Interviewer Tool to Understand How People Really Use AI
- IPL Tops Google’s Search List for 2025 as AI Breaks Into India’s Top 10
- TeamLease Names Suparna Mitra MD & CEO in Leadership Overhaul
Eight Roads Venture began investing out of Boston in 1969 as Fidelity Ventures. The firm backed the teams behind early innovators such as MCI, Continental Cablevision, and ATARI. It has now partnered with over 300 companies and investment teams across Asia and Europe. Fidelity’s backing allows the firm to stay focused and flexible in supporting its portfolio companies.
Eight Roads has built one of the broadest healthcare portfolios in India, focusing on sectors such as pharmaceuticals, medical devices, diagnostics, healthcare delivery, and health technology. It has supported many growth and late-stage startups with a global presence. The firm leverages its international network and patient capital to help scale companies across India, China, Japan, Europe, and the US.
Eight Roads Ventures has been investing in India since 2007, with a focus on healthcare, technology, consumer, fintech, and enterprise sectors. The firm manages approximately $1.6 billion in India. Key investments include PharmEasy, BankBazaar, FarEye, Toothsi, and Shadowfax. Eight Roads Ventures has also achieved notable exits in sectors such as SaaS, healthcare, and fintech.
